Login / Signup

Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.

Shadi YaghiTushar TrivediNils HenningerJames GilesAngela LiuMuhammad NagyAshutosh KaushalIdrees AzherBrian Mac GroryHiba FakhriKiersten Brown EspaillatSyed Daniyal AsadHemanth PasupuletiHeather MartinJose TanManivannan VeerasamyAva L LibermanCharles EsenwaNatalie ChengKhadean MoncrieffeIman Moeini-NaghaniMithilesh SidduErica ScherChristopher R Leon GuerreroMuhib KhanAmre NouhEva MistrySalah KeyrouzKaren Furie
Published in: Annals of neurology (2020)
In this multicenter real-world cohort, the recommended (4-14 days) time frame to start oral anticoagulation was not associated with reduced ischemic and hemorrhagic outcomes. Randomized trials are required to determine the optimal timing of anticoagulation initiation. ANN NEUROL 2020;88:807-816.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • type diabetes
  • clinical trial
  • ischemia reperfusion injury
  • oxidative stress
  • double blind
  • skeletal muscle